Clinical trial
Amatuximab for High Mesothelin Cancers
NCT01413451
Study timeline
Study start (unknown)2011-07-12Date precision: day
Registry last updated2019-12-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Carcinoma, Pancreatic Ductalunresolved
Mesotheliomaunresolved
Ovarian Neoplasmsunresolved
Carcinoma, Non-Small-Cell Lungunresolved
Interventions
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01413451 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.